Richard Capasso - Feb 10, 2022 Form 4 Insider Report for SQZ Biotechnologies Co (SQZB)

Role: Officer Title - Principal Accounting Officer and Chief Accounting Officer
Signature: /s/ Lawrence Knopf, Attorney-in-fact for Richard Capasso
Stock symbol: SQZB
Transactions as of: Feb 10, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/15/2022, 04:15 PM
Previous filing: Nov 16, 2021
Next filing: Jul 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SQZB	Stock Option	Award	$0	+42K		$0.00	42K	Feb 10, 2022	Common Stock	42K	$6.57	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable as to 25% of the underlying securities on February 10, 2023 and in 36 substantially equal monthly installments thereafter.

Remarks:

Officer Title - Principal Accounting Officer and Chief Accounting Officer